EDEN AVNI: Open Payments
NPI 1578076410 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 15 payments from 8 companies in 2025. Trend: 2023 $176 · 2024 $152 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $168 |
| GENZYME CORPORATION | 2 | $77 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Medtronic, Inc. | 1 | $34 |
| Optinose US, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, NUCALA, PROPEL, Xhance, General - Pain Management, FASENRA, NEFFY.
Industry payments across FL — which companies pay providers there.
